The diameter of the aortic valve is in direct proportion
|
|
- Morgan Chandler
- 6 years ago
- Views:
Transcription
1 The CarboMedics Top-Hat Supraannular Prosthesis José M. Bernal, MD, Rafael Martin-Duran, MD, José M. Rabasa, MD, and José M. Revuelta, MD Departments of Cardiovascular Surgery and Echocardiography, Hospital Universitario Valdecilla, Universidad de Cantabria, Santander, Spain Background. The CarboMedics Top-Hat supraannular prosthesis was designed to permit the implantation of a larger prosthesis. Methods. Between June 1993 and November 1996, 127 patients (average age, years) received a CarboMedics Top-Hat supraannular aortic prosthesis. The average follow-up was 15.7 months, and all surviving patients underwent echocardiographic study. This group is compared with 656 patients in whom a standard CarboMedics prosthesis was implanted and also with 2,927 patients who received other aortic prostheses. Results. Using the standard and the supraannular sizers, there was an average increase of one size in favor of the supraannular prosthesis: mm standard versus mm supraannular (p < 0.005). For each prosthesis size (19 to 23 mm), the body surface area of the patients in whom a CarboMedics supraannular prosthesis was implanted was significantly smaller than that in those who received a CarboMedics standard prosthesis or any other model. Hospital mortality was 3.9%, and late mortality was 5.5%. The actuarial survival was 86.5% 3.9% at 42 months. Conclusions. Using the CarboMedics supraannular prosthesis allows implantation of a larger prosthesis compared with the standard CarboMedics prosthesis or other models. This advantage is especially important in patients with a small aortic root. (Ann Thorac Surg 1999;67: ) 1999 by The Society of Thoracic Surgeons The diameter of the aortic valve is in direct proportion to the body surface area (BSA) of the patient. In general, BSA values lower than 1.7 m 2 are highly predictive of a small aortic root and thus indicate the need of a 19-mm prosthesis [1, 2]. In a Doppler echocardiographic study, González-Juanatey and colleagues [3] showed that various 19-mm prostheses of the latest generation result in substantial obstruction of the left ventricular outflow tract and less marked reduction in hypertrophy of the left ventricle compared with larger prostheses. Thus, the solutions to the problem of a small aortic root are to design a small prosthesis with better hemodynamics, to implant a larger prosthesis by aortic root enlargement, or to modify the sewing cuffs to take advantage of supraannular implantation. The CarboMedics Top-Hat supraannular prosthesis (introduced in 1993) is a standard valve in which the cuff has been transferred to the inflow level of the valve. As a result, the prosthesis sits above the annulus rather than within it. The valve housing protrudes into the aortic root like a top hat. Here we describe our clinical and echocardiographic experience with this aortic prosthesis. Accepted for publication Nov 3, Address reprint requests to Dr Bernal, Cirugía Cardiovascular, Hospital Universitario Valdecilla, Santander, Spain. Material and Methods In 1993, a prospective study was started to evaluate the Top-Hat prosthesis. Between June 1993 and November 1996, 127 patients underwent aortic valve replacement with the supraannular prosthesis. Of these 127 patients, 68 (53.5%) were women and 59 (46.5%) men. The average age was years (range, 28 to 81 years). In the preoperative period, 26 patients (20.5%) were in New York Heart Association class II, 79 (62.2%) were in class III, and 22 (17.3%) were in class IV. Primary valve replacement was performed on 92 patients (72.4%) and repeat valve replacement, on 35 patients (27.6%), 28 of whom had a previous aortic prosthesis in place. Seventysix patients (59.8%) were in sinus rhythm, 50 (39.4%) were in atrial fibrillation, and 1 had a pacemaker (0.8%). Hemodynamic and coronary angiographic examinations were done on 88 patients (69.3%). The remaining 39 patients (30.7%) were diagnosed by echocardiography exclusively. The left ventricular ejection fraction calculated by ventriculography ranged between 0.15 and 0.78 (average ejection fraction, ). On the basis of echocardiography, left ventricular function was considered normal in 29 patients and depressed in 10. Isolated aortic valvulopathy was diagnosed in 83 patients (65.4%), mitral and aortic valvulopathy in 40 patients (31.5%), and mitral, aortic, and tricuspid valvulopathy in 4 patients (3.1%). The aortic lesion was pure stenosis or a double lesion with preponderance of stenosis in 106 patients (83.5%) and insufficiency in 21 patients (16.5%). The cause 1999 by The Society of Thoracic Surgeons /99/$20.00 Published by Elsevier Science Inc PII S (99)
2 1300 BERNAL ET AL Ann Thorac Surg CARBOMEDICS SUPRAANNULAR VALVE 1999;67: of the valvular disease was degenerative or calcific in 63 patients (49.6%), rheumatic in 33 patients (26%), and active infectious endocarditis in 3 patients (2.4%); of the 28 patients (22%) with a previously placed prosthesis, 25 had structural deterioration of the bioprosthesis, and 1 each had valvular thrombosis, valvular dehiscence, and elective bioprosthesis explantation. Thirteen patients (10.2%) had concomitant coronary artery disease. Surgical Technique and Valve Measurement The operation was performed with standard cardiopulmonary bypass and moderate hypothermia (28 to 30 C). Myocardial protection was achieved with intermittent blood cardioplegia, antegrade initially and retrograde as of January After aortic valve resection and decalcification of the valve root when necessary, both the standard sizer and the supraannular sizer were used in each patient. The aortic prosthesis was implanted in the supraannular position. Pledgets were placed in the ventricular surface of the native aortic ring and knots, in the aortic aspect of the prosthetic sewing cuff. In patients with low-lying coronary ostia or a narrow sinotubular junction, stitches were arranged in an imaginary plane at the level of the most distal point of the annulus of each aortic leaflet. Forty 19-mm prostheses (31.5%) were implanted, mm prostheses (45.7%), and mm prostheses (22.8%). Forty-four patients had assoociated mitral valve procedures: mitral valve replacement with the Carbo- Medics standard prosthesis in 40 and mitral valve repair in 4. Four patients underwent associated tricuspid valve procedures: replacement with a Hancock II bioprosthesis in 1 and repair in 3. Associated myocardial revascularization with an average of 1.5 grafts per patient was performed in 13 patients. The surviving patients were maintained on a regimen of Coumadin (crystalline warfarin sodium), with a recommended international normalized ratio ranging between 2.5 and 3.5. The ratio was modified according to the individual requirements of each patient during follow-up. Doppler echocardiographic study was performed after discharge between postoperative months 1 and 42. In 91.3% of the survivors, this study was carried out 3 months or more after operation. All examinations were done with the patient in the left lateral decubitus position with simultaneous electrocardiographic recording. A commercially available echocardiograph with continuous wave (cw), pulsed wave (pw), and color Doppler capabilities (Vingmed 750) was used. All measurements were done on-line and recorded on VHS videotape for off-line analysis if necessary. Peak and mean gradients were calculated using the modified Bernoulli equation [4]: pressure gradient (P) 4(V 2 2 V 1 1)(V 2 2, distal velocity; V 1 1, proximal velocity). Because of the usually narrow left ventricular outflow tract in these patients, special care was taken not to neglect V 1. Effective orifice area was obtained with the continuity equation: A 2 A 1 V 1 /V 2 (A 2, orifice effective area of the prosthesis, A 1, left ventricle outflow tract area) [5 7]. Three consecutive beats in sinus rhythm and eight in atrial fibrillation were analyzed. At the conclusion of follow-up, 90 (78.3%) of the 115 patients alive were studied at our center by the same observer, and 25 patients (21.7%) were followed in other hospitals by the referring cardiologists. Follow-up of the survivors was completed between October and December Follow-up ranged from 30 days to 42 months with an average time of 15.7 months and an accumulated follow-up of 175 patient-years. Follow-up was 100% complete. Statistical Analysis The Patient Analysis and Tracking System database, Version (Dendrite Clinical Systems, Inc, Portland, OR) was used. Values are shown as the mean the standard deviation. The Student t test was used for the comparison of quantitative variables. Actuarial curves were produced by the Cox actuarial method. The implanted prosthesis size study was done by comparing measurements obtained with the CarboMedics standard and Top-Hat sizers. Results Mortality and Morbidity Five patients (3.9%) died in the hospital, and 7 patients (5.5%) died late. The causes of the five hospital deaths were low cardiac output (n 3), sepsis (n 1), and pulmonary thromboembolism (n 1). Of the late deaths, five were due to cardiac-related causes: unknown (n 2), thromboembolism (n 1), cardiac insufficiency resulting from dehiscence of a mitral valve prosthesis (n 1), and prosthetic valve endocarditis treated medically, (n 1). Two of the late deaths had noncardiac causes: cancer of the colon (n 1) and cancer of the pancreas (n 1). The overall actuarial survival was 86.5% 3.9% at 42 months (Fig 1). Excluding deaths from noncardiac causes, the actuarial survival was 88.9% 3.9% at 42 months of follow-up. Fig 1. Actuarial survival curve at 42 months after operation.
3 Ann Thorac Surg BERNAL ET AL 1999;67: CARBOMEDICS SUPRAANNULAR VALVE 1301 Table 1. Body Surface Area of Patients Given CarboMedics Top-Hat Supraannular, CarboMedics Standard, or Other Type of Prosthesis in 19- to 23-mm Sizes a Type of Prosthesis 19 mm 21 mm 23 mm Top-Hat (n 127) b b b Standard (n 656) Other (n 2,927) a Data are shown in square meters and as the mean the standard deviation. b Significance: p 0.001, Top-Hat versus Standard and Top-Hat versus Other. Fig 2. Comparison between measurements obtained using Carbo- Medics standard and supraannular ( Top-Hat ) aortic valve sizers. Two patients required a repeat operation: 1 for dehiscence of a mitral valve prosthesis and 1 because of mitral and tricuspid valve disease. One patient had early prosthetic aortic valve endocarditis and died without a repeat operation. Three central (neurologic event) thromboembolic episodes were recorded: one resulted in death, and two were without sequelae. Two patients sustained major anticoagulant-related hemorrhages and 11 patients, minor hemorrhages. Of the 115 patients alive at the conclusion of follow-up, 96 (83.5%) were in New York Heart Association functional class I, 16 (13.9%) were in class II, and 3 (2.6%) were in class III. Comparison of Valve Measurements Figure 2 shows the comparison between the measurements obtained using the CarboMedics standard and Top-Hat supraannular prosthesis sizers. The average of values obtained with the standard sizers was mm and that obtained with the supraannular sizers, mm ( p 0.005). Of all 3,710 aortic valve replacements performed in our institution, 406 were reoperations involving a previous 19- to 23-mm aortic prosthesis of any type; the size of the prosthesis implanted and that of the prosthesis explanted were measured. The average size of the Top-Hat prosthesis implanted in the 28 patients with a previous aortic valve replacement was mm, and the average size of the prosthesis explanted was mm ( p not significant). Among the 656 patients in whom a Carbo- Medics standard prosthesis was implanted, 102 had had a previous aortic valve replacement. The average size of the implanted prosthesis was mm, and the average size of the explanted prosthesis was mm ( p 0.001). Of the 2,927 patients in whom an aortic prosthesis other than the CarboMedics standard or the Top-Hat was implanted, 276 had undergone aortic valve replacement previously. The average implanted prosthesis size was mm, and the average size of the explanted prosthesis was mm ( p 0.001). The comparison between the average BSAs of patients receiving the three different sizes of Top-Hat prostheses (19, 21, and 23 mm) versus patients given a Carbo- Medics standard prosthesis or another type of prosthesis in the same sizes is shown in Table 1. For all valve sizes, the BSA was significantly smaller ( p 0.001) with the Top-Hat prosthesis. Doppler Echocardiographic Assessment Postoperative values obtained at echocardiographic assessment of each patient did not show significant differences in function. Ninety patients (78.3%) were seen in our center and 25 patients (21.7%) in other hospitals. Table 2 shows the Doppler echocardiographic values obtained for each size of Top-Hat prosthesis, 19, 21, and 23 mm. Of the patients studied, 40.8% were in atrial fibrillation. Comment The problem of the small aortic root has been addressed in various ways. The techniques to enlarge the aortic root permit the implantation of a larger-sized prosthesis than the size of the native aortic root. However, they are not free from added risk [7] and considerably lengthen the time of myocardial ischemia. Aortic homografts are appropriate for the small aortic root, as their hemodynamic behavior is excellent, but their durability as well as their availability is limited. The use of porcine stentless bioprostheses is a newer alternative for dealing with the small aortic root [8, 9]. However, the durability of these Table 2. Results of Doppler Echocardiography for CarboMedics Top-Hat Supraannular Prosthesis in 19- to 23-mm Sizes a Variable 19 mm (n 40) 21 mm (n 58) 23 mm (n 29) Peak gradient (mm Hg) Mean gradient (mm Hg) Effective orifice area (cm 2 ) a Data are shown as the mean the standard deviation.
4 1302 BERNAL ET AL Ann Thorac Surg CARBOMEDICS SUPRAANNULAR VALVE 1999;67: prostheses is not yet known, and indications do not include the total population needing aortic valve replacement. Bioprostheses and mechanical prostheses of the latest generation have not solved the problem of the small aortic root [3]. At present, patients in whom a 19-mm prosthesis is implanted can be considered to have a poorer prognosis because of the persistence of high transvalvular gradients and the inability to substantially reduce left ventricular hypertrophy [10, 11]. Another newer option is to modify the sewing cuff so as to create a supraannular prosthesis. This allows the use of a larger size than would be possible for a prosthesis implanted in the intraannular position. Initial experience with these sewing cuff modifications has been published [12 15]. One study analyzes the clinical and echocardiographic results in the largest published series to date with the Top-Hat prosthesis. Analysis of the possible advantages of using prostheses designed specifically for supraannular implantation is complex. In our opinion, the use of sizers to determine prosthesis to implant is subjective. Forcing the use of a prosthesis a size larger than the correct size can cause serious complications, such as obstruction of the coronary ostia or dehiscence around the prosthesis, which are more frequent in cases of severely calcified aortic roots. The surgical technique of implantation of the CarboMedics supraannular valve is crucial to prevent complications such as ostial obstruction of coronary arteries or paraprosthetic leak. In our experience since 1974, the problem of the small aortic root has been very evident in our patient population. Of the 3,710 aortic valve replacements performed, 27.3% of the patients had a BSA smaller than 1.60 m 2, which correlates directly with the 28.1% implantation rate of 19- and 21-mm prostheses. Of this 28.1%, 7.4% were 19 mm and 20.7%, 21 mm. The comparison between the measurements taken with the CarboMedics standard and Top-Hat prosthesis sizers showed a significant difference of one size in favor of the Top-Hat. Although this outcome agrees with that of Roedler and coauthors [15], some subjectivity may be involved. On the other hand, when an aortic prosthesis (mechanical or biological) is explanted, the native aortic root is severely fibrosed and rigid, and it frequently becomes necessary to implant a smaller-sized prosthesis. This was clear in our experience when the average size of the prosthesis implanted and that of the one explanted were measured. For the CarboMedics standard prosthesis or other prostheses, an average of one size is lost: mm and mm, respectively, for prostheses implanted and mm and mm, respectively, for those explanted ( p 0.001). In contrast, in this series, aortic valve prostheses averaging mm in size were explanted from 28 patients, and a Top-Hat prostheses of the same size, mm, were implanted ( p not significant). The similarity in sizes demonstrates the advantage of the supraannular implant. The comparison of the average BSAs shows that patients with a Top-Hat prosthesis had a significantly smaller BSA for each of the three sizes (19, 21, and 23 mm) than that of patients for whom a CarboMedics standard prosthesis or other type of valve substitute was used. In practice, this means that BSAs being equal, a larger Top-Hat prosthesis can be used. These analyses must be looked at carefully because of the characteristics of the groups studied, although they do suggest that the use of a prosthesis designed specifically for supraannular implantation constitutes an especially interesting advantage in patients with small aortic roots. The Doppler echocardiographic study was performed in most survivors (91.3%) 3 months or more after operation (range, 3 to 42 months). The data obtained do not differ significantly from those published by other groups [16, 17] for the CarboMedics standard prosthesis. As the mechanical part of the Top-Hat prosthesis has not been modified from the CarboMedics standard prosthesis, this finding is reasonable. The difference between the two prostheses does not affect the valve areas for each size, but it does allow the opportunity to implant a larger size in each patient. Because of the number of patients and the length of follow-up, analysis of the clinical results in terms of mortality and morbidity contributes limited information. As the modification of the Top-Hat prosthesis alters only the sewing cuff, the clinical results should not vary in regard to those published for the CarboMedics standard prosthesis [18, 19]. In our experience, modification of the sewing cuff has not produced any incidence of paravalvular leak. We conclude that in our experience, the CarboMedics supraannular Top-Hat prosthesis allows the implantation of a larger-sized prosthesis than would otherwise be possible. This option is especially valuable for patients with a small aortic root. References 1. Chambers J. Echocardiography and the small aortic root. J Heart Valve Dis 1996;5(Suppl 3): Franzen SF, Huljebrant IE, Konstantinov IE, Nylander E, Olin CL. Aortic valve replacement for aortic stenosis in patients with small aortic root. J Heart Valve Dis 1996;5 (Suppl 3): González-Juanatey JR, Garcia-Acuña JM, Vega M, et al. Influence of size of aortic valve prostheses on hemodynamics and change in left ventricular mass: implications for the surgical management of aortic stenosis. J Thorac Cardiovasc Surg 1996;112: Rijsterborgh H, Roelendt J. Doppler assessment of aortic stenosis: Bernoulli revisited. Ultrasound Med Biol 1987;13: Otto CM, Pearlman AS, Comess KA, Reamer RP, Janko CL, Hunsman LL. Determination of stenotic aortic valve area in adults using Doppler echocardiography. J Am Coll Cardiol 1986;7: Oh JK, Taliercio CP, Holmes DR, et al. Prediction of the severity of aortic stenosis by Doppler aortic valve area determination: prospective Doppler-catheterization correlation in 100 patients. J Am Coll Cardiol 1988;11: Abdelnoor M, Hall KV, Nitter-Hauge S, Linberg H, Ovrum E. Prognostic factors in aortic valve replacement associated with narrowing aortic roots. Scand J Thorac Cardiovasc Surg 1986;20:
5 Ann Thorac Surg BERNAL ET AL 1999;67: CARBOMEDICS SUPRAANNULAR VALVE Walther T, Falk V, Diegeler A, et al. Stentless bioprostheses for small aortic root. J Heart Valve Dis 1996;5(Suppl 3): Sintek CF, Fletcher AD, Khonsari S. Small aortic root in the elderly: use of stentless bioprosthesis. J Heart Valve Dis 1996;5(Suppl 3): Kratz JM, Sade RM, Crawford FA Jr, Crumbley AJ III, Stroud MR. The risk of small St. Jude aortic valve prostheses. Ann Thorac Surg 1994;57: Sim EKW, Orszulak TA, Schaff HV, Shub C. Influence of prosthesis size on change in left ventricular mass following aortic valve replacement. Eur J Cardio-thorac Surg 1994;8: De Paulis R, Sommariva L, Russo F, et al. Doppler echocardiography evaluation of the CarboMedics valve in patients with small aortic anulus and valve prosthesis body surface area mismatch. J Thorac Cardiovasc Surg 1994;108: De Brux JL, Subayi JB, Binuani P, Laporte J. Dopplerechocardiographic assessment of the CarboMedics supraannular Top-Hat prosthetic heart valve in the aortic position. J Heart Valve Dis 1996;5(Suppl 3):S De Paulis R, Sommariva L, De Matteis GM, et al. Hemodynamic performances of small diameter CarboMedics and St. Jude valves. J Heart Valve Dis 1996;5(Suppl 3):S Roedler S, Moritz A, Wutte M, Hoda R, Wolner E. The CarboMedics top hat supraannular prosthesis in the small aortic root. J Cardiac Surg 1995;10: Chambers J, Cross J, Deverall P, Sowton E. Echocardiographic description of the CarboMedics bileaflet prosthetic heart valve. J Am Coll Cardiol 1993;21: Ihlen H, Molstad P, Simonsen S, et al. Hemodynamic evaluation of the CarboMedics prosthetic heart valve in the aortic position: comparison of noninvasive and invasive techniques. Am Heart J 1992;123: Copeland JG III, Sethi GK, North American team of clinical investigators for the CarboMedics prosthetic heart valve. Four-year experience with the CarboMedics valve: the North American experience. Ann Thorac Surg 1994;58: Bernal JM, Rabasa JM, Gutierrez-Garcia F, Morales C, Nistal JF, Revuelta JM. The CarboMedics valve: experience with 1,049 implants. Ann Thorac Surg 1998;65: The Annals of Thoracic Surgery Cumulative Index The Annals of Thoracic Surgery 31-year cumulative index, volume 1 through volume 60, January 1965 through December 1995, is available in two versions: in print (ISBN ) and on CD-ROM (ISBN ). Both print and CD-ROM versions contain subject and author indexes for the 31 years of the journal to date. The CD-ROM also contains all of the journal s published scientific abstracts; hypertext links between article titles, subject headings, authors, and abstracts; a search function that allows full-text, Boolean, and keyword searches; and functions to select and format references for future use. The CD-ROM is both DOS/ Windows and Macintosh compatible. The price is $95.00 for the CD-ROM version, $95.00 for the print version, or only $ for both the CD-ROM and print versions. Contact Elsevier Science Inc to place your order. Telephone (212) ; Fax (212) by The Society of Thoracic Surgeons Ann Thorac Surg 1999;67: /99/$20.00 Published by Elsevier Science Inc
The CarboMedics bileaflet prosthetic heart was introduced
The CarboMedics Valve: Experience With 1,049 Implants José M. Bernal, MD, José M. Rabasa, MD, Francisco Gutierrez-Garcia, MD, Carlos Morales, MD, J. Francisco Nistal, MD, and José M. Revuelta, MD Department
More informationTSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD
TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)
More informationDoes Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?
Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles
More informationOutcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease
Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve
More informationLong-term results (22 years) of the Ross Operation a single institutional experience
Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department
More informationReconstruction of the intervalvular fibrous body during aortic and
Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body: An analysis of clinical outcomes Nilto C. De Oliveira, MD Tirone E. David, MD Susan Armstrong, MSc Joan Ivanov,
More information2017 Cardiovascular Symposium CARDIAC SURGERY UPDATE: SMALLER INCISIONS AND LESS COUMADIN DAVID L. SAINT, MD
2017 Cardiovascular Symposium CARDIAC SURGERY UPDATE: SMALLER INCISIONS AND LESS COUMADIN DAVID L. SAINT, MD David L Saint M.D. Tallahassee Memorial Hospital Southern Medical Group Division of Cardiothoracic
More information16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900
CLINICAL COMMUNIQUé 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 69 The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 69, was introduced into clinical
More informationNineteen-Millimeter Aortic St. Jude Medical Heart Valve Prosthesis: Up to Sixteen Years Follow-up
Nineteen-Millimeter Aortic St. Jude Medical Heart Valve Prosthesis: Up to Sixteen Years Follow-up Dilip Sawant, FRCS, Arun K. Singh, MD, William C. Feng, MD, Arthur A. Bert, MD, and Fred Rotenberg, MD
More informationCarpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience
SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://www.annalsthoracicsurgery.org/cme/ home. To take the CME activity related to this article, you must have either an STS member
More informationReoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment
Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment W.R.E. Jamieson, MD; L.H. Burr, MD; R.T. Miyagishima, MD; M.T. Janusz, MD; G.J. Fradet, MD; S.V. Lichtenstein, MD; H. Ling, MD Background
More informationPROSTHETIC VALVE BOARD REVIEW
PROSTHETIC VALVE BOARD REVIEW The correct answer D This two chamber view shows a porcine mitral prosthesis with the typical appearance of the struts although the leaflets are not well seen. The valve
More informationEchocardiographic Evaluation of Mitral Valve Prostheses
Echocardiographic Evaluation of Mitral Valve Prostheses Dennis A. Tighe, M.D., FACC, FACP, FASE Cardiovascular Medicine University of Massachusetts Medical School Worcester, MA www.asecho.org 1 Nishimura
More informationProsthetic valve dysfunction: stenosis or regurgitation
Prosthetic valve dysfunction: stenosis or regurgitation Jean G. Dumesnil MD, FRCP(C), FACC, FASE(Hon) Quebec Heart and Lung Institute, Québec, Québec No disclosures Possible Causes of High Gradients in
More informationFavorable Results in Patients with Small Size CarboMedics Heart Valves in the Aortic Position
Favorable Results in Patients with Small Size CarboMedics Heart Valves in the Aortic Position Kazuhito Imanaka, MD, Shinichi Takamoto, MD, and Akira Furuse, MD 2 Hemodynamic performance of the CarboMedics
More informationCLINICAL COMMUNIQUE 16 YEAR RESULTS
CLINICAL COMMUNIQUE 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 Introduction The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 6900, was introduced
More informationHani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz
Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for
More informationRegression of Hypertrophy After Carpentier-Edwards Pericardial Aortic Valve Replacement
Regression of Hypertrophy After Carpentier-Edwards Pericardial Aortic Valve Replacement Steven S. Khan, MD, Robert J. Siegel, MD, Michele A. DeRobertis, RN, Carlos E. Blanche, MD, Robert M. Kass, MD, Wen
More informationClinical material and methods. Copyright by ICR Publishers 2003
Fourteen Years Experience with the CarboMedics Valve in Young Adults with Aortic Valve Disease Jan Aagaard 1, Jens Tingleff 2, Per V. Andersen 1, Christel N. Hansen 2 1 Department of Cardio-Thoracic and
More informationThe operative mortality rate after redo valvular operations
Clinical Outcomes of Redo Valvular Operations: A 20-Year Experience Naoto Fukunaga, MD, Yukikatsu Okada, MD, Yasunobu Konishi, MD, Takashi Murashita, MD, Mitsuru Yuzaki, MD, Yu Shomura, MD, Hiroshi Fujiwara,
More informationAortic valve replacement in predominant aortic stenosis: What is an appropriate size valve?
IJTCVS Joshi et al 141 Aortic valve replacement in predominant aortic stenosis: What is an appropriate size valve? Kishore Joshi, M.Ch., Sachin Talwar, M.Ch., Devagourou Velayoudham, M.Ch., Arkalgud Sampath
More information25 different brand names >44 different models Sizes mm
Types of Prosthetic Valves BIOLOGIC STENTED Porcine xenograft Pericardial xenograft STENTLESS Porcine xenograft Pericardial xenograft Homograft (allograft) Autograft PERCUTANEOUS MECHANICAL Bileaflet Single
More informationDoppler-Echocardiographic Assessment of Carbomedics Prosthetic Valves in the Mitral Position
Doppler-Echocardiographic Assessment of Carbomedics Prosthetic Valves in the Mitral Position Chee-Siong Soo, MRCP, Mestres Ca, MD, Monica Tay, Joon-Kuan Yeoh, MRCP, Eugene Sim, FRCS, and M. Choo, FRCP,
More informationManagement of Difficult Aortic Root, Old and New solutions
Management of Difficult Aortic Root, Old and New solutions Hani K. Najm MD, Msc, FRCSC,, FACC, FESC Chairman, Pediatric and Congenital Heart Surgery Cleveland Clinic Conflict of Interest None Difficult
More informationBicuspid aortic root spared during ascending aorta surgery: an update of long-term results
Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,
More informationIntensity of oral anticoagulation after implantation of St. Jude Medical mitral or multiple valve replacement: lessons learned from GELIA (GELIA 5)
European Heart Journal Supplements () 3 (Supplement Q), Q39 Q43 Intensity of oral anticoagulation after implantation of St. Jude Medical mitral or multiple valve replacement: lessons learned from GELIA
More informationP have been used for mitral and aortic valve replacement
A -Year Comparison of Mitral Valve Replacement With Carpentier-Edwards and Hancock Porcine Bioprostheses P. Perier, MD, A. Deloche, MD, S. Chauvaud, MD, J. C. Chachques, MD, J. Relland, MD, J. N. Fabiani,
More informationT sors in the following aspects: the porcine aortic valve
Clinical and Hemodynamic Assessment of the Hancock I1 Bioprosthesis Tirone E. David, MD, Susan Armstrong, MSc, and Zhao Sun, MA Division of Cardiovascular Surgery, The Toronto Hospital and University of
More informationHemodynamic Assessment. Assessment of Systolic Function Doppler Hemodynamics
Hemodynamic Assessment Matt M. Umland, RDCS, FASE Aurora Medical Group Milwaukee, WI Assessment of Systolic Function Doppler Hemodynamics Stroke Volume Cardiac Output Cardiac Index Tei Index/Index of myocardial
More informationCase. 15-year-old boy with bicuspid AV Severe AR with moderate AS. Ross vs. AVR (or AVP)
Case 15-year-old boy with bicuspid AV Severe AR with moderate AS Ross vs. AVR (or AVP) AMC case 14-year-old boy with bicuspid AV Severe AS with mild AR Body size Bwt: 55 kg, Ht: 154 cm, BSA: 1.53 m 2 Echocardiography
More informationPrimary Tissue Valve Degeneration in Glutaraldehvde-Preserved Porcine Biomostheses: Hancock I Vekus Carpentier-Edwards at 4- to 7-Years Follow-up
Primary Tissue Valve Degeneration in Glutaraldehvde-Preserved Porcine Biomostheses: A Hancock I Vekus Edwards at 4- to 7-Years Follow-up Francisco Nistal, M.D., Edurne Artifiano, M.D., and Ignacio Gallo,
More informationIncidence of prosthesis-patient mismatch in patients receiving mitral Biocor porcine prosthetic valves
INTERVENTION/VALVULAR HEART DISEASE ORIGINAL ARTICLE Cardiology Journal 2016, Vol. 23, No. 2, 178 183 DOI: 10.5603/CJ.a2016.0011 Copyright 2016 Via Medica ISSN 1897 5593 Incidence of prosthesis-patient
More informationThe stentless bioprosthesis has many salient features that
Aortic Valve Replacement with the Medtronic Freestyle Xenograft Using the Subcoronary Implantation Technique D. Michael Deeb, MD The stentless bioprosthesis has many salient features that make it an attractive
More informationHani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia.
Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia. Decision process for Management of any valve Timing Feasibility
More informationEffect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival
Effect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival Sukumaran K. Nair, FRCS (C Th), Gauraang Bhatnagar, MBBS, Oswaldo Valencia, MD, and Venkatachalam Chandrasekaran,
More informationA 20-year experience of 1712 patients with the Biocor porcine bioprosthesis
Acquired Cardiovascular Disease Mykén and Bech-Hansen A 2-year experience of 1712 patients with the Biocor porcine bioprosthesis Pia S. U. Mykén, MD, PhD, a and Odd Bech-Hansen, MD, PhD b Objective: The
More information15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses
ORIGINAL CONTRIBUTION 15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses WR Eric Jamieson, MD, Eva Germann, MSc, Michel R Aupart, MD 1, Paul H Neville, MD 1, Michel A Marchand,
More informationEight-Year Results of Aortic Root Replacement With the Freestyle Stentless Porcine Aortic Root Bioprosthesis
Eight-Year Results of Aortic Root Replacement With the Freestyle Stentless Porcine Aortic Root Bioprosthesis Neal D. Kon, MD,* Robert D. Riley, MD, Sandy M. Adair, RN, Dalane W. Kitzman, MD, and A. Robert
More informationIn , three studies described patients
Heart 2001;85:337 341 VALVE DISEASE Should patients with asymptomatic mild or moderate aortic stenosis undergoing coronary artery bypass surgery also have valve replacement for their aortic stenosis? Shahbudin
More informationA Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision
A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction
More informationPatient/prosthesis mismatch: how to evaluate and when to act?
Patient/prosthesis mismatch: how to evaluate and when to act? Svend Aakhus, MD, PhD Oslo University Hospital, Norway Disclosures: No conflict of interest Types of aortic valve prostheses (AVR) Mechanical
More informationInterventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504
Transcatheter valve-in-valve e implantation for aortic bioprosthetic valve dysfunction Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504 Your responsibility This
More informationClinical event rates with the On-X bileaflet mechanical heart valve: A multicenter experience with follow-up to 12 years
Clinical event rates with the On-X bileaflet mechanical heart valve: A multicenter experience with follow-up to 12 years John B. Chambers, MD, FRCP, FACC, a Jose L. Pomar, MD, PhD, FETCS, b Carlos A. Mestres,
More informationEDITORIAL TX ET CSP ACD GTS ACD
Vitale et al Clinical evaluation of St Jude Medical Hemodynamic Plus versus standard aortic valve prostheses: The Italian multicenter, prospective, randomized study Nicola Vitale, MD, PhD Ilaria Caldarera,
More informationAORTIC VALVE REPLACEMENT WITH FREEHAND AUTOLOGOUS PERICARDIUM
AORTIC VALVE REPLACEMENT WITH FREEHAND AUTOLOGOUS PERICARDIUM Fifty-one patients with a mean age of 31.2 years underwent aortic valve replacement with glutaraldehyde-treated autologous pericardium. Pure
More informationProf. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM
The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?
More informationAssessment of Hemodynamics Properties of a New-Type Artificial Heart Valve Prosthesis Using Catheterization and Echocardiography
American Journal of Hematology 81:563 567 (2006) Assessment of Hemodynamics Properties of a New-Type Artificial Heart Valve Prosthesis Using Catheterization and Echocardiography Y.J. Zeng, 1,4 * S.W. Xu,
More informationHow to Avoid Prosthesis-Patient Mismatch
How to Avoid Prosthesis-Patient Mismatch Philippe Pibarot, DVM, PhD, FACC, FAHA, FASE, FESC Canada Research Chair in Valvular Heart Diseases INSTITUT UNIVERSITAIRE DE CARDIOLOGIE ET DE PNEUMOLOGIE DE QUÉBEC
More informationThe CarboMedics prosthetic valve (Sulzer CarboMedics,
Long-Term Result of 1144 CarboMedics Mechanical Valve Implantations Chang Hyun Kang, MD, Hyuk Ahn, MD, Kyung Hwan Kim, MD, and Ki-Bong Kim, MD Department of Thoracic and Cardiovascular Surgery, Seoul National
More informationW e have previously reported the results of a randomised
715 CARDIOVASCULAR MEDICINE Twenty year comparison of a mechanical heart valve with porcine bioprostheses H Oxenham, P Bloomfield, D J Wheatley, R J Lee, J Cunningham, R J Prescott, H C Miller... See end
More informationHemodynamics and Early Clinical Performance of the St. Jude Medical Regent Mechanical Aortic Valve
Hemodynamics and Early Clinical Performance of the St. Jude Medical Regent Mechanical Aortic Valve David S. Bach, MD, Marc P. Sakwa, MD, Martin Goldbach, MD, Michael R. Petracek, MD, Robert W. Emery, MD,
More informationPPM: How to fit a big valve in a small heart
PPM: How to fit a big valve in a small heart Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC King Abdulaziz Cardiac Centre National Guard Health Affairs Riyadh, Saudi Arabia GHA meeting Muscat
More informationREGRESSION OF LEFT VENTRICULAR HYPERTROPHY AFTER AORTIC VALVE REPLACEMENT FOR AORTIC STENOSIS WITH DIFFERENT VALVE SUBSTITUTES
REGRESSION OF LEFT VENTRICULAR HYPERTROPHY AFTER AORTIC VALVE REPLACEMENT FOR AORTIC STENOSIS WITH DIFFERENT VALVE SUBSTITUTES Ruggero De Paulis, MD Luigi Sommariva, MD Luisa Colagrande, MD Giovanni Maria
More informationJournal of the American College of Cardiology Vol. 44, No. 9, by the American College of Cardiology Foundation ISSN /04/$30.
Journal of the American College of Cardiology Vol. 44, 9, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.04.062 Relation
More informationAlthough mitral valve replacement (MVR) is no longer the surgical
Surgery for Acquired Cardiovascular Disease Ruel et al Late incidence and predictors of persistent or recurrent heart failure in patients with mitral prosthetic valves Marc Ruel, MD, MPH a,b Fraser D.
More informationThe increase in the lifespan of the western population
Outcome After Aortic Valve Replacement in Octogenarians Bruno Chiappini, MD, Nicola Camurri, MD, Antonio Loforte, MD, Luca Di Marco, MD, Roberto Di Bartolomeo, MD, and Giuseppe Marinelli, MD Department
More informationON-X and St.Jude Medical mechanical prosthesis. A paradox concept: they are equal but different
Accepted Manuscript ON-X and St.Jude Medical mechanical prosthesis. A paradox concept: they are equal but different Francesco Formica, MD, Stefano D Alessandro, MD, FECTS, Umberto Benedetto PII: S0022-5223(19)30709-3
More informationExperience with 500 Stentless Aortic Valve Replacements
Experience with 500 Stentless Aortic Valve Replacements Dimitrios C. Iliopoulos, MD Cardiac Surgeon Ass. Professor of Surgery University of Athens, School of Medicine I declare no conflict of interest
More informationClosed mitral valvotomy was first reported by Cutler
Mitral Commissurotomy, a Technique Outdated? Long-Term Follow-up Over a Period of 35 Years Christian Detter, MD, Teddy Fischlein, MD, Christina Feldmeier, MD, Georg Nollert, MD, Hermann Reichenspurner,
More informationBall Valve (Smeloff-Cutter) Aortic Valve Replacement Without Anticoagulation
Ball Valve (Smeloff-Cutter) Aortic Valve Replacement Without Anticoagulation Begonia Gometza, MD, and Carlos M. G. Duran, MD, PhD Department of Cardiovascular Diseases, King Faisal Specialist Hospital
More informationThe Edge-to-Edge Technique f For Barlow's Disease
The Edge-to-Edge Technique f For Barlow's Disease Ottavio Alfieri, Michele De Bonis, Elisabetta Lapenna, Francesco Maisano, Lucia Torracca, Giovanni La Canna. Department of Cardiac Surgery, San Raffaele
More informationAortic Valve Practice Guidelines: What Has Changed and What You Need to Know
Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know James F. Burke, MD Program Director Cardiovascular Disease Fellowship Lankenau Medical Center Disclosure Dr. Burke has no conflicts
More informationAssessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington
Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME
More informationT annulus (521 mm in diameter) is tempered by concerns
Clinical and Hemodynamic Performance of the 19-mm Carpentier-Edwards Porcine Bioprosthesis Robert M. Bojar, MD, Hassan Rastegar, MD, Douglas D. Payne, MD, Charles A. Mack, MD, and Steven L. Schwartz, MD
More informationIt is controversial whether to perform aortic valve replacement
Management of Patients With Mild Aortic Stenosis Undergoing Coronary Artery Bypass Grafting James W. Tam, MD, Roy G. Masters, MD, Ian G. Burwash, MD, Alain D. Mayhew, BS, and Kwan-Leung Chan, MD University
More informationValve prosthesis-patient mismatch (PPM) was first defined
Impact of Valve Prosthesis-Patient Mismatch on Short-Term Mortality After Aortic Valve Replacement Claudia Blais, BSc; Jean G. Dumesnil, MD; Richard Baillot, MD; Serge Simard, MS; Daniel Doyle, MD; Philippe
More informationQUANTIFICATION AND PREVENTION TECHNIQUES OF PROSTHESIS-PATIENT MISMATCH
QUANTIFICATION AND PREVENTION TECHNIQUES OF PROSTHESIS-PATIENT MISMATCH 1,2 Radu A. SASCĂU 3 Cristina OLARIU 1,2 Cristian STĂTESCU 1 Internal Medicine Department, Gr.T.Popa University of Medicine and Pharmacy,
More informationAortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years experience in 130 patients
Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years experience in 130 patients Augusto D Onofrio, MD, Stefano Auriemma, MD, Paolo Magagna, MD, Alessandro Favaro, MD,
More informationAn anterior aortoventriculoplasty, known as the Konno-
The Konno-Rastan Procedure for Anterior Aortic Annular Enlargement Mark E. Roeser, MD An anterior aortoventriculoplasty, known as the Konno-Rastan procedure, is a useful tool for the cardiac surgeon. Originally,
More informationThe vast majority of patients, especially children, who
Technique of Mechanical Pulmonary Valve Replacement John M. Stulak, MD, and Joseph A. Dearani, MD The vast majority of patients, especially children, who require pulmonary valve replacement (PVR), obtain
More informationORIGINAL PAPER. The long-term results and changing patterns of biological valves at the mitral position in contemporary practice in Japan
Nagoya J. Med. Sci. 78. 369 ~ 376, 2016 doi:10.18999/nagjms.78.4.369 ORIGINAL PAPER The long-term results and changing patterns of biological valves at the mitral position in contemporary practice in Japan
More informationTHE IMPACT OF AGE, CORONARY ARTERY DISEASE, AND CARDIAC COMORBIDITY ON LATE SURVIVAL AFTER BIOPROSTHETIC AORTIC VALVE REPLACEMENT
THE IMPACT OF AGE, CORONARY ARTERY DISEASE, AND CARDIAC COMORBIDITY ON LATE SURVIVAL AFTER BIOPROSTHETIC AORTIC VALVE REPLACEMENT Gideon Cohen, MD Tirone E. David, MD Joan Ivanov, MSc Sue Armstrong, MSc
More informationAortic Valve Replacement or Heart Transplantation in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction
Aortic Valve Replacement or Heart Transplantation in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction L.S.C. Czer, S. Goland, H.J. Soukiasian, S. Gallagher, M.A. De Robertis, J. Mirocha,
More informationWhich Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?
Ann Thorac Cardiovasc Surg 2013; 19: 428 434 Online January 31, 2013 doi: 10.5761/atcs.oa.12.01929 Original Article Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should
More informationIschemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications
Surgery for Acquired Cardiovascular Disease Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Eugene A. Grossi, MD Judith D. Goldberg, ScD Angelo
More informationLong-Term Results With the Medtronic-Hall Valvular Prosthesis
Long-Term Results With the Medtronic-Hall Valvular Prosthesis Cary W. Akins, MD Cardiac Surgical Unit, Massachusetts General Hospital, Boston, Massachusetts Background. Although more than 170,000 Medtronic-
More informationLate incidence and predictors of persistent or recurrent heart failure in patients with aortic prosthetic valves
Late incidence and predictors of persistent or recurrent heart failure in patients with aortic prosthetic valves Marc Ruel, MD, MPH a,b Fraser D. Rubens, MD a Roy G. Masters, MD a Andrew L. Pipe, MD a
More informationPART II ECHOCARDIOGRAPHY LABORATORY OPERATIONS ADULT TRANSTHORACIC ECHOCARDIOGRAPHY TESTING
PART II ECHOCARDIOGRAPHY LABORATORY OPERATIONS ADULT TRANSTHORACIC ECHOCARDIOGRAPHY TESTING STANDARD - Primary Instrumentation 1.1 Cardiac Ultrasound Systems SECTION 1 Instrumentation Ultrasound instruments
More informationMedtronic Mosaic porcine bioprosthesis: Assessment of 12-year performance
Medtronic Mosaic porcine bioprosthesis: Assessment of 12-year performance W. R. Eric Jamieson, MD, a Friedrich-Christian Riess, MD, b Peter J. Raudkivi, MD, c Jacques Metras, MD, d Edward F. G. Busse,
More informationThe ATS Medical Open Pivot heart valve (ATS Medical, 10-Year Experience With the ATS Mechanical Valve in the Mitral Position
10-Year Experience With the ATS Mechanical Valve in the Mitral Position Constantin Stefanidis, MD, Albert M. Nana, MD, Didier De Cannière, MD, PhD, Martine Antoine, MD, Jean-Luc Jansens, MD, Chi-Hoang
More informationIndication, Timing, Assessment and Update on TAVI
Indication, Timing, Assessment and Update on TAVI Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Starr- Edwards Mechanical
More information14 Valvular Stenosis
14 Valvular Stenosis 14-1. Valvular Stenosis unicuspid valve FIGUE 14-1. This photograph shows severe valvular stenosis as it occurs in a newborn. There is a unicuspid, horseshoe-shaped leaflet with a
More informationThe clinical experience reported in recent Western series has provided
Surgery for Acquired Cardiovascular Disease Yu et al Long-term evaluation of Carpentier-Edwards porcine bioprosthesis for rheumatic heart disease Hsi-Yu Yu, MD a Yi-Lwun Ho, MD b Shu-Hsun Chu, MD c Yih-Sharng
More informationAnatomy determines the close vicinity of the sinuses of
Aortic Valve Reimplantation According to the David Type I Technique Matthias Karck, MD, and Axel Haverich, MD Department of Thoracic and Cardiovascular Surgery, Hannover Medical School, Hannover, Germany.
More informationLong-term Experience with the Bjork-Shiley Monostrut Tilting Disc Valve
J Korean Med Sci 2007; 22: 1060-4 ISSN 1011-8934 DOI: 10.3346/jkms.2007.22.6.1060 Copyright The Korean Academy of Medical Sciences Long-term Experience with the Bjork-Shiley Monostrut Tilting Disc Valve
More informationPROVEN PLUS. Introducing the Avalus Aortic Valve by Medtronic.
PROVEN PLUS. Introducing the Avalus Aortic Valve by Medtronic. With more than 40 years of heart valve innovations, we took proven valve design concepts and adapted them for excellent implantability for
More informationPresenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose
Presenter Disclosure Patrick O. Myers, M.D. No Relationships to Disclose Aortic Valve Repair by Cusp Extension for Rheumatic Aortic Insufficiency in Children Long term Results and Impact of Extension Material
More informationEACTS Adult Cardiac Database
EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list
More informationSurgical Treatment for Valvular Heart Disease
Chapter 34 Surgical Treatment for Valvular Heart Disease Peter J. K. Starek Competency of the atrioventricular valves allows blood to enter the ventricles, where pressure is generated. When adequate systolic
More informationValvular Heart Disease
Valvular Heart Disease B K Singh, MD, FACC Disclosures: None 1 CARDIAC CYCLE S2 S2=A2P2 S1=M1T1 S4 S1 S3 2 JVP Carotid S1 Slitting of S2 S3 S4 Ejection click Opening snap Dynamic Auscultation What is the
More informationSt. Jude Medical and CarboMedics Mechanical Heart Valves in the Aortic Position
Clinical Investigation Ozer Kandemir, MD Hilmi Tokmakoglu, MD Ulku Yildiz, MD Tevfik Tezcaner, MD A. Cem Yorgancioglu, MD Ilhan Gunay, MD Kaya Suzer, MD Yaman Zorlutuna, MD St. Jude Medical and CarboMedics
More informationHOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY?
HOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY? John D. Carroll, MD Professor, Director of Interventional Cardiology and Co-Medical Director of the Cardiac and Vascular Center, University of Colorado
More informationESC/EACTS Guidelines for the Management of Valvular Heart Disease
ES/EATS Guidelines for the Management of Valvular Heart Disease European Journal of ardio-thoracic Surgery 2012 - Why do we need new guidelines on the management of valvular disease? New evidence has been
More informationEleven years experience with the Biocor stentless aortic bioprosthesis: clinical and hemodynamic follow-up with long-term relative survival rate
European Journal of Cardio-thoracic Surgery 22 (2002) 912 921 www.elsevier.com/locate/ejcts Eleven years experience with the Biocor stentless aortic bioprosthesis: clinical and hemodynamic follow-up with
More informationPATIENT BOOKLET MEDTRONIC MITRAL AND TRICUSPID HEART VALVE REPAIR
PATIENT BOOKLET MEDTRONIC MITRAL AND TRICUSPID HEART VALVE REPAIR ARE MEDTRONIC HEART VALVE REPAIR THERAPIES RIGHT FOR YOU? Prosthetic (artificial) heart valve repair products are used by physicians to
More informationAbileaflet mechanical valve is described by a nominal size, which
Surgery for Acquired Cardiovascular Disease Chambers et al Nominal size in six bileaflet mechanical aortic valves: A comparison of orifice size and biologic equivalence John B. Chambers, MD, FACC a Lionel
More informationNon-cardiac Surgery in Valvular Heart Disease
Jafar Golshahi, MD; Shahnaz Aram, MD Abstract Background- Valvular heart disease is one of the common complications of acute rheumatic fever, which manifests its clinical complications one or two decades
More informationDivision of Cardiothoracic Surgery, University of Miami, Miller School of Medicine, and Jackson Memorial Hospital, Miami, Florida
Multiple Valve Surgery with Beating Heart Technique Marco Ricci, MD, Francisco Igor B. Macedo, MD, Maria R. Suarez, MD, Michael Brown, CCP, Julia Alba, MD, and Tomas A. Salerno, MD Division of Cardiothoracic
More informationEchocardiographic variables associated with mitral regurgitation after aortic valve replacement for aortic valve stenosis
The Egyptian Heart Journal (2013) 65, 135 139 Egyptian Society of Cardiology The Egyptian Heart Journal www.elsevier.com/locate/ehj www.sciencedirect.com ORIGINAL ARTICLE Echocardiographic variables associated
More informationEvaluation of St. Jude Medical Valve s Long-term Function by Doppler Echocardiography
Evaluation of St. Jude Medical Valve s Long-term Function by Doppler Echocardiography Akira Sezai, MD, Motomi Shiono, MD, Kenji Akiyama, MD, Yukihiko Orime, MD, Hiroaki Hata, MD, Shinya Yagi, MD, Tomonori
More information